The dual role of Schlafen11 in brain tumors: Jekyll and Hyde
Manabu Natsumeda(Niigata University), Makoto Oishi(Niigata University), Masayasu Okada(Niigata University Medical and Dental Hospital), Junko Murai(Ehime University), C A EBERHART, J Watanabe(Niigata University), Chinatsu Kakinuma(Gunma University), Haruhiko Takahashi(Niigata University), Akiyoshi Kakita(Niigata University), Satoshi Nakata(Gunma University), Calixto-Hope G Lucas, Yoshihiro Tsukamoto(Niigata University)
Cited by 0
Related Papers
Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition
|Oncotarget|2016|292
CNS high‐grade neuroepithelial tumor with <i>BCOR</i> internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue
|Brain Pathology|2017|125
<i>SLFN11</i> Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma
|Clinical Cancer Research|2015|103